Promising antileishmanial activity of novel imidazole antifungal drug luliconazole against Leishmania major: In vitro and in silico studies
ConclusionThese results show the potent activity of luliconazole at extremely low concentrations against L. major. It may therefore be considered as a new candidate for treatment of leishmaniasis in the near future.Graphical abstract
Source: Journal of Global Antimicrobial Resistance - Category: Infectious Diseases Source Type: research
More News: Abelcet | Antimicrobial Resistance | HIV-Leishmania Co-infection | Infectious Diseases | Ketoconazole | Parasitic Diseases | Parasitology | Study | Toxicology